In this work, we extensively studied pan-Trk IHC in a large cohort of mesenchymal neoplasms using two antibody clones: EPR17341 (RTU Assay, Roche/Ventana) and A7H6R (Cell Signaling Technologies). This evidence concerns the gene NTRK1 and mesenchymal cell neoplasm.